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Background: Reprogrammed cells, including induced pluripotent stem cells (iPSCs) and nuclear transfer embryonic
stem cells (NT-ESCs), are similar in many respects to natural embryonic stem cells (ESCs). However, previous studies
have demonstrated that iPSCs retain a gene expression signature that is unique from that of ESCs, including
differences in microRNA (miRNA) expression, while NT-ESCs are more faithfully reprogrammed cells and have better
developmental potential compared with iPSCs.
Results: We focused on miRNA expression and explored the difference between ESCs and reprogrammed cells, especially
ESCs and NT-ESCs. We also compared the distinct expression patterns among iPSCs, NT-ESCs and NT-iPSCs. The results
demonstrated that reprogrammed cells (iPSCs and NT-ESCs) have unique miRNA expression patterns compared with ESCs.
The comparison of differently reprogrammed cells (NT-ESCs, NT-iPSCs and iPSCs) suggests that several miRNAs have key
roles in the distinct developmental potential of reprogrammed cells.
Conclusions: Our data suggest that miRNAs play a part in the difference between ESCs and reprogrammed cells, as well as
between MEFs and pluripotent cells. The variation of miRNA expression in reprogrammed cells derived using different
reprogramming strategies suggests different characteristics induced by nuclear transfer and iPSC generation, as well as
different developmental potential among NT-ESCs, iPSCs and NT-iPSCs.Background
Embryonic stem cell (ESC) research has made remark-
able progress since the establishment of the first human
embryonic stem cell line in 1998 [1]. The pluripotent na-
ture of ESCs makes them valuable as a tool to model
embryonic development and for regenerative medicine
in vitro. They are also valuable as a cell resource for
transplantation. However, the ethical issues surrounding
the derivation of ESCs from embryos hinders the clinical
application of ESCs and many countries limit or ban
their use [2].
In 2006, Yamanaka brought pluripotent cell research
into a new era by showing that over-expression of four* Correspondence: yan.jin@siat.ac.cn; yxjin@sibs.ac.cn
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could reprogram mouse somatic cells into ESC-like cells
that showed similar morphology and pluripotent nature
to that of ESCs [3]. They named these ESCs-like cells
“induced pluripotent stem cells” (iPSCs). Research into
iPSCs has since proceeded at an astonishing pace and
has included the establishment of human iPSCs and high
efficiency induction of iPSCs with fewer transcription
factors in combination with microRNAs (miRNAs) or
small compounds [4-9]. With ongoing advances in
miRNA biology, these findings may lead to a nonviral,
nontranscription-factor mediated procedure for gen-
erating iPSCs for use not only in basic stem cell biol-
ogy studies, but also in high throughput generation of
human iPSC clones from large patient populations.
Despite the robustness of iPSCs technology, human
somatic cell nuclear transfer (SCNT) research remains
an important approach for regenerative medicine [10,11].
The recent establishment of human pluripotent ESCs bytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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erating patient-matched nuclear transfer (NT)-ESCs for
studies of disease mechanisms and for developing specific
therapies [12]. Since the initial discovery in amphibians in
1962, SCNT success in a range of different mammalian
species has demonstrated that such reprogramming activ-
ity is universal [12-14]. Direct comparisons between iPSCs
and NT-ESCs in the mouse indicated that SCNT-based
reprogramming is more efficient in resetting the epi-
genetic identity of parental somatic cells [15,16]. The
breakthrough discovery of such a reprogramming event
provides a powerful means to generate and regenerate un-
limited pluripotent stem cells directly from body tissue
cells. Yet, full understanding of the mechanism involved,
called somatic cell reprogramming (SCR), remains elusive.
iPSCs share the majority properties with ESCs, such as
morphology, differentiation, pluripotency, DNA methy-
lation and gene expression; however, there is a wide
range of evidence showing that there are subtle yet sub-
stantial differences between these cell types [17-22].
These studies demonstrated that iPSCs are characterizedFigure 1 Deep sequencing of the small RNA transcriptomes in MEF, E
removal of adaptors, low quality tags and contaminants. The y-axis depicts
in each dataset. Red box outlines the peak of read length ranging from 20
RNA species. The sequences obtained from each sample were subjected to
at right).by a unique gene and miRNA expression signature as
well as a CpG methylation pattern that distinguishes
them from ESCs. Recently, several miRNAs have been
shown to enhance iPSC reprogramming when expressed
with combinations of the four key factors [23,24]. These
miRNAs belong to families of miRNAs that are expressed
preferentially in ESCs and are thought to help maintain
the ESC phenotype. How these miRNAs enhance iPSC re-
programming is unclear but may involve their ability to
regulate the cell cycle. Further experiments demonstrated
that the miR-302/367 cluster can directly reprogram
mouse and human somatic cells to an iPSCs state in
the absence of any of the previously described iPSCs
transcription factors [25-29]. These results show that
miRNAs may be the crucial factors of iPSCs as well as
having key roles in their induction.
The purpose of this study was to determine the miRNA
profiles and to identify the differentially expressed miR-
NAs in ESCs, reprogrammed cells and mouse embryonic
fibroblasts (MEFs) by deep sequencing analysis. Previous
studies reported that reprogrammed cells generated bySCs and reprogrammed cells. A. Read length distribution (nt) after
the percentage of read lengths relative to the total number of reads
to 24 nt. B. Proportion of total/unique small tags matched to different
a series of sequence similarity searches using specific databases (listed
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velopmental potential [16]. We therefore generated three
kinds of mouse reprogrammed cells: iPSCs, NT-ESCs and
NT-iPSCs. We evaluated the differences between the miR-
NAs signatures of ESCs, MEFs and the variously derived
reprogrammed cells.
Results
Sequencing the small RNA transcriptomes in different cell
lines
To generate miRNA profiles of ESCs, reprogrammed
cells and MEFs by deep sequencing analysis, we used
three different batches of RNA samples for MEFs and
ESCs, and two different batches of RNA samples for
NT-ESCs, iPSCs and NT-iPSCs (which were all derived
from the same MEF line). Small RNA transcriptomes
from 12 RNA samples from five different cell lines were
analyzed by next generation Solexa sequencing. The total
sequencing reads are shown in Additional file 1: Table S1,
which shows that high quality sequence was generated
based on the high percent of clean reads and the high
consistency among the different batches of RNA samples
from the same cell lines. After removal of adapter se-
quence, low quality tags and contaminants, analysis of all
reads showed the read length distribution main peaks atFigure 2 Distinct expression pattern of miRNAs between ESCs and iP
calculated from the variance stabilizing transformed data. The distance o
A larger number means less similarity between two samples. B. miRNAs
expression patterns between ESCs and iPSCs. Each group of miRNAs is i20–24 nt. This indicates that mature miRNAs were
enriched in the sequencing samples (Figure 1A). The
composition of small RNAs depicted in Figure 1B illus-
trates the different distribution of RNA species in the dif-
ferent cell lines. The MEF cells expressed more miRNAs
than ESCs or the reprogrammed cells.
Distinct miRNA expression signatures are associated with
differently derived cells
Previous studies have reported different miRNA expres-
sion profiles in ESCs and iPSCs [17]. In addition, repro-
grammed cells generated by different reprogramming
strategies show different developmental potential [16].
However, detailed miRNAs profiles of these cells have
not so far been explored. We, therefore, evaluated differ-
ences among miRNA signatures of differently derived
cells. As shown in Additional file 2: Figure S1, clustering
analyses of all samples based on miRNA expression
demonstrated a significant difference between MEFs and
pluripotent cells, as well as major similarities among the
differently derived pluripotent stem cells. The heatmap
representing the distances between the samples also
showed the same signature (Figure 2A). However, des-
pite similarities in the pluripotent nature and the
miRNA expression profiles of ESCs and reprogrammedSCs. A. A heatmap showing the distances between the samples as
f two samples is indicated in the crossing box of the two samples.
(VST > 10) were grouped by k-means clustering based on the different
ndicated by a colored sidebar.
Figure 3 Differentially expressed miRNAs in ESCs and
reprogrammed cells. A. Venn Diagram shows the number of
differentially expressed miRNAs in ESCs and the three
reprogrammed cell types. The top 50 miRNAs that are differentially
expressed between ESCs and each reprogrammed cell type are
represented in each circle. The intersection of the three circles
indicates 34 miRNAs that are commonly differentially expressed
between ESCs and reprogrammed cells. B. Heatmap shows the 34
common reprogrammed cell-specific miRNAs. Except for miR-294,
295, 182, 183, mentioned above, the expression of the remaining
miRNAs was similar in ESCs and MEFs. These miRNAs were
grouped into two major classes indicated by green and red sidebars.
The expression level of the green class of miRNAs was lower in
reprogrammed cells than in ESCs and MEFs and the expression
level of the red class was higher in reprogrammed cells than in
ESCs and MEFs.
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pattern was still evident after clustering analysis, which
is indicated by a colored sidebar in Figure 2B. In addition,
the three reprogrammed cell types also presented obvious
differences in miRNAs expression (Figure 2B).Differentially expressed miRNAs in ESCs and
reprogrammed cells
To determine whether miRNAs are expressed in ESCs
and reprogrammed pluripotent cells at similar levels, ex-
pression profiling of all known miRNAs was performed
on mouse ESCs and reprogrammed pluripotent cells, in-
cluding iPSCs, NT-ESCs and NT-iPSCs. A Venn diagram
shows the top 50 miRNAs that were differentially expressed
between each reprogrammed cell type and ESCs, and indi-
cates 34 miRNAs that were differentially expressed in all re-
programmed pluripotent cells, compared to mouse ESCs
(Figure 3A, Additional file 3: Table S2). The detailed expres-
sion profiles of the 34 miRNAs are illustrated in a heatmap
(Figure 3B). Among them, the expression of miR-290, miR-
294, miR-182 and miR-183 were lower in MEF cells than in
pluripotent cells. However, the expression of the other 30
miRNAs was similar in ESCs and MEFs but was signifi-
cantly different in reprogrammed cells compared to ESCs or
MEFs (Figure 3B). In detail, 13 miRNAs were highly
expressed and 17 miRNAs were expressed at low levels
in reprogrammed cells and were significantly different
compared to those in ESCs. The miRNAs showing the
maximum difference between MEFs and pluripotent
cells were miR-290 and miR-294, while miR-126 and
miR-140 showed the maximum difference between repro-
grammed cells and somatic cells. These results indicate that
the difference between ESCs and reprogrammed cells
might be attributed, at least in part, to differently expressed
miRNAs. The following target prediction analysis using
bioinformatics described the KEGG pathway and the result
showed the enrichment of target genes diffused distribution
which was different from the pluripotent specific miRNAs
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Figure 4).
Distinct expression of miRNAs in the three types of
reprogrammed cell
In addition to studying differences in miRNA expression
profiles between ESCs and reprogrammed cells, we also
compared the expression of miRNAs in the differently
derived reprogrammed cells, NT-ESCs, iPCSc and NT-
iPSCs. Our previous study demonstrated that different
reprogramming strategies resulted in distinct develop-
mental potential and found that NT-ESCs had better de-
velopmental potential compared with iPSCs. Furthermore,
subsequent nuclear transfer to iPSCs did not rescue, but
rather increased the developmental deficiency of iPSCs,
resulting in NT-iPSCs having reduced developmental abil-
ity [16]. Our current miRNA analysis produced four clus-
ters that were differentially expressed among the different
pluripotent cells in which groups 1, 2 and 4 represented
differences that were common to iPSCs and the nuclearFigure 4 Target gene prediction. Target genes of miRNAs in the four plu
to KEGG pathways by mirPath. Not all miRNAs in the four pluripotency-rela
in the mirPath database. Some miRNAs that have less than 100 target gene
pathway enrichment of some pluripotency related miRNAs. The bubble co
enrichment. The size of the bubble scaled the percentage of the enriched
names are listed at the left of the plot and the function class names of thetransfer strategy, while group 3 represented the sequential
decreasing expression similar as the developmental ability
in different pluripotent cells (Figure 5, Additional file 6:
Table S4). The critical miRNAs were expressed differently
between differently reprogrammed cells, suggesting that
iPSCs had a miRNA signature that defines them as unique
from ESCs and nuclear transfer-derived cells.
MiRNAs potentially contribute to the pluripotency of ESCs
and reprogrammed cells
A significant difference was present between the miRNA
profiles of MEFs and pluripotent cells. Figure 6A and
Additional file 7: Table S5 list the top 50 differentially
expressed miRNAs which were grouped into six classes
by k-means clustering (Figure 6B, Additional file 8: Table
S6). Interestingly, all 50 miRNAs were expressed at sig-
nificantly higher levels in pluripotent cells than in MEF
cells which demonstrated that these miRNAs were pluri-
potent specific. Figure 7 and Additional file 9: Table S7
illustrate the four major families of pluripotent-specificripotency related classes were predicted by microT v4.0 and mapped
ted classes were analyzed because some of them are not yet included
s were also excluded in this plot. The bubble plot shows the KEGG
lor scaled the enrichment score. A larger score means more significant
target genes among total target miRNAs of a miRNA. KEGG pathway
pathways are listed in the right panel.
Figure 5 Top differentially expressed miRNAs in three kinds of reprogrammed cells. The differentially expressed miRNAs were grouped by
k-means clustering. MiRNAs with VST values of more than 10 in at least one reprogrammed cells with an adjusted p value less than 0.05 (ANOVA)
were included in this analysis. For profiling, miRNA expression value was centred to the mean.
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ilies, which are widely recognized to be pluripotent specific.
The miRNA families clustered together on pluripotent
cells, as well as the data from our sequencing analysis,
demonstrated the crucial roles of these miRNAs in pluripo-
tency. Ensemble data shows the analysis of the four cluster-
ing miRNAs, indicating that upstream sequence elements
of these miRNAs were mainly ESCs-specific transcript fac-
tor binding sites, DNase 1 footprint protection sites, poly-
merase protection sites or histone modification features
(Additional file 10: Figure S3), which further demonstrated
the pluripotent signature of these miRNAs. We then ana-
lyzed the target genes of the miRNAs in the four pluripo-
tency related classes by microT v4.0 and mapped these
genes to KEGG pathways using mirPath. The target genes
were mostly enriched in cancer related and signal transduc-
tion pathways, which are also characteristic of immortalized
cells, such as pluripotent cells (Figure 4, Additional file 11:
Table S8).
Discussion
We prepared 12 samples from five different cell lines to
analyze miRNA expression profiles. The consistent miRNA
expression profiles generated from different batches of
samples from the same cell lines indicated accurate sample
preparation and sequencing. Meanwhile, high quality se-
quences with a high percentage of clean reads were
achieved in all samples. Moreover, our data from dif-
ferent pluripotent cells, including iPSCs, NT-ESCs, ESCsand NT-iPSCs present similar miRNAs features as com-
pared with MEF miRNAs.
Previous studies have demonstrated the distinct signa-
tures of iPSCs and ESCs for gene expression, epigenetic
and miRNAs profiles [17]. In the present study, we ex-
amined three kinds of reprogrammed cells to identify
differences in miRNA expression between reprogrammed
cells and ESCs. Thirty-four miRNAs were identified to be
differentially expressed in the three reprogrammed cells
compared with ESCs, among which miR-24 and miR-370
were previously reported in literature. From the heatmap
depiction of miRNA expression, we found that miRNAs
were differentially expressed not only relative to ESCs but
also to MEFs, which showed similar expression levels
compared with reprogrammed cells, suggesting that re-
programmed cells have miRNAs signatures different to
those of somatic cells. The target gene prediction and
mapping to KEGG pathways illustrated the diffused distri-
bution of target genes of differentially expressed miRNAs
for both highly and lowly expressed miRNAs in repro-
grammed cells.
To detect differences between ESCs and reprogrammed
cells, we compared miRNA expression in different repro-
grammed cells, derived using different strategies, includ-
ing iPSCs, NT-ESCs and NT-iPSCs all of which were
derived from the same MEFs. Our previous data suggested
different development potential with NT-ESCs > iPSCs >
NT-iPSCs. In the present study, we identified differentially
expressed miRNAs in the three kinds of reprogrammed
Figure 6 MiRNAs potentially contribute to the pluripotency of ESCs and iPSCs. A. The top 50 differentially expressed miRNAs in ESCs and
MEF cells were grouped as six classes by k-means clustering. Each miRNA class is indicated by colored sidebars. The first four classes of miRNAs
were considered as pluripotency-related miRNAs. VST counts value is scaled by a color key. B. The expression profiles across all samples of the first
four classes of miRNAs are plotted. The color of each plot was in accordance with the color of the sidebar in Figure 3A.
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groups with significant variations. Group 1 represented the
variation of NT-ESCs and NT-iPSCs > iPSCs, group 2 and
4 showed the difference of iPSCs >NT-ESCs and NT-
iPSCs, which demonstrated that the nuclear transfer strat-
egy induced different expression of miRNAs compared
with the strategy of using four transcription factors to in-
duce iPSCs. Meanwhile, group 3 with NT-ESCs > iPSCs >
NT-iPSCs represented variation that was similar to previ-
ously demonstrated sequential development potential. Pre-
viously, studies have reported that miR-302 could replace
all transcription factors to reprogram somatic cells to
iPSCs [27-30]. Interestingly, the miR-302 family was repre-
sented in group 4 and was highly expressed in iPSCs,indicating that iPSCs might be more highly dependent on
miR-302 expression than pluripotent cells produced by the
SCNT method.
It has been clearly shown that various types of cell
vary not only in the expression of their coding genes,
but also in the expression of their noncoding genes. In
the present study, we compared differences in miRNAs
expression between MEFs and ESCs and among MEF-
derived iPSCs, NT-ESCs and NT-iPSCs to identify pluripo-
tent specific miRNAs. The 50 top differentially expressed
miRNAs were assigned to four clusters which were almost
all highly expressed in pluripotent cells. Among them, miR-
290 and miR-302 clusters were identified in previous stud-
ies to play key roles in pluripotency maintenance. The
Figure 7 Histograms of the miRNAs from the four major pluripotency related miRNA clusters. Histograms illustrate the expression of the miRNAs from
the four major miRNA clusters identified in the four classes of pluripotency-related miRNAs (Additional file 9: Table S7). A. miR-290-295 cluster. B. miR-302a-302d
cluster. C. miR-465a-465c cluster. D. miR-18b-363 cluster. The color of each plot is in accordance with the color of the sidebar in Figure 3A. The gray plots
indicate the miRNAs that were not called by the criteria of the top 50 differentially expressed miRNAs but they are located in the listed miRNAs clusters.
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onstrate the reliability of our sequence data. Furthermore,
the target gene analysis showed that four miRNAs clusters
mainly targeted genes involved in cancers and signaltransduction pathways. The common characteristics of cell
proliferation and immortalization are shared between can-
cer cells and pluripotent cells, as are activated signal trans-
duction pathways.
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In conclusion, we first report differentially expressed
miRNAs among ESCs, MEFs and three kinds of repro-
grammed cells. The unique expression of miRNAs in
pluripotent cells mainly represents acquired expression
of miRNAs, while the higher and lower expression levels
of miRNAs in ESCs compared with reprogrammed cells
may reflect the difference between naturally pluripotent
cells and reprogrammed cells. Finally, the variation in
miRNA expression among reprogrammed cells derived
using different reprogramming strategies suggests differ-
ent characteristics induced by nuclear transfer and iPSC
generation, as well as different developmental potential
among NT-ESCs, iPSCs and NT-iPSCs.
Methods
Cell culture
Mouse ES cell line (E14) was maintained in our lab.
iPSCs were obtained by infecting MEFs (C57B6/129SvJae
F1) with a dox-inducible lentivirus carrying the four re-
programming factors (Oct4, Sox2, Klf4 and c-Myc). NT-
ESCs were established by reprogramming MEFs into
ESCs using nuclear transfer. To establish NT-iPSCs, the
nucleus of an iPSC was transferred into an enucleated
oocyte. NT-iPSCs were established to reflect the com-
bination of nuclear transfer and iPS technologies. iPSCs,
NT-ESCs, and NT-iPSCs were derived from the same
MEF cells. All the cells were cultured and maintained as
described previously [16]. All experiments were approved
by the Ethics Committee of Shanghai Institute of Bio-
chemistry and Cell Biology.
RNA preparation and sequencing
Total RNA was isolated using TRIzol reagent. RNA qual-
ity was assessed with an Agilent 2100 bioanalyzer. Total
RNAs from MEFs, ESCs and the three reprogrammed cell
types were subjected to Solexa sequencing, performed by
BGI-Shenzhen, Shenzhen, China. The sequencing data
have been deposited with the Gene Expression Omnibus
repository (www.ncbi.nlm.nih.gov/geo) under accession
number GSE52950.
Data analysis and statistics
After removal of adaptors, low quality tags and contami-
nants from the sequenced tags, clean reads were anno-
tated. MiRNA reads were analyzed using the DESeq
package [31] in R language [32]. Normalization and vari-
ance stabilizing transformations (VST) were performed
before further analysis. Differently expressed miRNAs
and sample distances between any two kinds of samples
were calculated by DESeq. MiRNAs with variance stabil-
izing transformed values of more than 10 were clustered
using the gplots package [33].We present a hypothesis that miRNAs contributing to
pluripotency should meet at least two criteria. First,
these miRNAs should be highly expressed in ESCs and
expressed at lower levels in MEF cells. Second, these
miRNAs should also show relatively high levels of ex-
pression in iPSCs. Based on these criteria, the expression
profiles of the top 50 miRNAs that were more highly
expressed in ESCs than in MEF cells were grouped by
k-means clustering using the Vegan package [34]. The
genome context of each miRNA was extracted from
miRbase [35-38] and presented using the Ensembl Gen-
ome Browser. Target genes of miRNAs were predicted and
enriched in KEGG pathways using mirPath [39]. The en-
richment results are presented in a “bubble plot” using the
ggplot2 package [40].
To identify iPSC-specific miRNAs, the top 50 miRNAs
differently expressed between ESCs and each reprogrammed
cell type were screened and 34 miRNAs that were com-
monly differentially expressed between ESCs and all repro-
grammed cell types were identified as iPSC-specific
miRNAs. These miRNAs were grouped by k-means clus-
tering. The target genes of these miRNAs were also
mapped to KEGG pathways.
To identify differentially expressed miRNAs in the
three reprogrammed cell types, miRNAs with a VST
value more than 10 in at least one reprogrammed cell
type were analyzed. MiRNAs with an adjusted p value
less than 0.05 (ANOVA) were identified as differentially
expressed miRNAs in these different reprogrammed cells,
and were grouped by k-means clustering using the Vegan
package.Additional files
Additional file 1: Table S1. Description of sequencing data.
Additional file 2: Figure S1. Distinct expression patterns of miRNAs
between MEFs and pluripotent cells. Clustering analysis of all samples
based on miRNA expression whose counts was more than 10 after
variance stabilizing transformation in at least one sample (VST > 10).
Additional file 3: Table S2. 50 most differentially expressed miRNAs in
iPSCs and ESCs.
Additional file 4: Figure S2. The KEGG pathway enrichment of the
target genes of the two classes of miRNA. Not all miRNAs in the four
pluripotency related classes were analyzed because some of them are
not yet included in the database. Some miRNAs that have less than 100
target genes were also excluded in this plot. The bubble plot shows the
KEGG pathway enrichment of some pluripotency related miRNAs. The
bubble color scaled the enrichment score. A larger score means more
significant enrichment. The size of the bubble scaled the percentage of
the enriched target genes among total target miRNAs of a miRNA. KEGG
pathway names are listed at the left of the plot and the function class
names of the pathways are listed in the right panel.
Additional file 5: Table S3. KEGG pathway analysis of target genes that
showed the most difference among the three reprogramming cells and
ESCs. MiRNAs in the “gain” group were highly expressed in the three
reprogrammed cells but lowly expressed in ESCs. MiRNAs in the “loss”
group were highly expressed in ESCs but lowly expressed in the three
reprogrammed cells.
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http://www.biomedcentral.com/1471-2164/15/488Additional file 6: Table S4. Differently expressed miRNAs (VST value
more than 10 and adjusted p value less than 0.05) were grouped by k-means
clustering. Four groups were identified. “n” means these miRNA didn’t fall in
any groups.
Additional file 7: Table S5. Top 50 differentially expressed miRNAs in
ESCs and MEF cells.
Additional file 8: Table S6. Six classes of miRNA grouped by k-means
from the 50 differentially expressed miRNAs in ESCs and MEF cells.
Additional file 9: Table S7. MiRNA gene clusters identified in the first
four classes of pluripotency-related miRNAs. ‘nc’ means that these
miRNAs are not in any classes.
Additional file 10: Figure S3. Ensemble gene browser image showing
the four miRNA clusters identified in the four classes of pluripotency-related
miRNAs. ESC-specific transcript factor binding sites, DNase 1 footprint protection
sites, polymerase protection sites and histone modification features are
indicated.
Additional file 11: Table S8. miRNA target genes enriched in KEGG
pathways. ‘Counts’ means the number of target genes that mapped to
the corresponding pathway.
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